| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.1B | $13.5B | $12.9B | $12.5B | $11.1B | $10.8B | $2.7B | $2.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.2B | $2.4B | $2.3B | $1.9B | $1.7B | $2.2B | $0.6B | $0.5B |
| Net Income | $1.0B | $1.0B | $1.1B | $0.4B | $1.3B | $1.1B | $-0.1B | $0.1B |
| EPS (Basic) | $1.77 | $1.70 | $1.92 | $0.71 | $2.35 | $1.99 | $-0.20 | $0.25 |
| EPS (Diluted) | $1.76 | $1.70 | $1.92 | $0.71 | $2.35 | $1.99 | $-0.20 | $0.25 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $55.9B | $52.0B | $48.8B | $46.1B | $45.4B | $44.5B | $42.3B | $40.1B |
| Current Assets | $3.0B | $2.8B | $2.6B | $2.4B | $3.2B | $3.7B | $2.4B | $2.4B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.2B | $1.5B | $1.7B | $0.6B | $0.4B |
| Total Liabilities | $42.0B | $38.3B | $37.9B | — | — | — | — | — |
| Current Liabilities | $5.3B | $5.0B | $5.4B | $4.0B | $4.4B | $5.0B | $4.9B | $4.6B |
| Stockholders' Equity | $12.5B | $12.5B | $10.4B | $10.2B | $8.7B | $7.2B | $7.0B | $6.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $2.9B | $1.4B | $2.7B | $2.8B | $1.4B | $2.5B | $1.4B |
| Investing Cash Flow | $-5.1B | $-4.3B | $-3.7B | $-3.1B | $-2.6B | $-2.9B | $-2.9B | $-3.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.3B | $1.4B | $2.2B | $-0.9B | $-0.5B | $2.6B | $0.7B | $1.4B |